CTNM · NASDAQ
Contineum Therapeutics (CTNM) Stock Price & Fundamentals
Contineum Therapeutics (CTNM) closed at $455.61 on Oct 9, 2026, up 0.19% from the previous close of $454.75.
Share price, past year
1Y +13.77%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $455.61 |
| Sep 30, 2026 | $461.53 |
| Aug 31, 2026 | $439.45 |
| Jul 31, 2026 | $423.12 |
| Jun 30, 2026 | $419.98 |
| May 29, 2026 | $404.50 |
| Apr 30, 2026 | $407.53 |
| Mar 31, 2026 | $405.28 |
| Feb 27, 2026 | $419.77 |
| Jan 30, 2026 | $419.16 |
| Dec 31, 2025 | $404.27 |
| Nov 28, 2025 | $403.93 |
| Oct 31, 2025 | $407.48 |
Key statistics
- Market cap
- $10.52B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$57.56M
- Shares outstanding
- 23.1M
- Dividend yield
- —
- 52-week range
- $393.91 – $463.64
Contineum Therapeutics's market cap is $10.52B, based on a share price of $455.61 and 23.1M shares outstanding as of Oct 27, 2025.
Financials
Contineum Therapeutics reported revenue of $0.00 for fiscal 2024, down 100.00% from fiscal 2023.
Contineum Therapeutics reported a net loss of $59.98M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $0.00 | −100.0% | −$42.26M | — | −$2.18 | −$33.36M |
| FY2023ended Dec 31, 2023 | $50.00M | — | $22.72M | 45.4% | $0.08 | $18.94M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$10.27M | −$0.40 |
| Q2 FY2024ended Jun 30, 2024 | $0.00 | — | −$0.39 |
| Q3 FY2023ended Sep 30, 2023 | $0.00 | — | −$2.69 |
| Q2 FY2023ended Jun 30, 2023 | $50.00M | — | $0.84 |
Company profile
- Name
- Contineum Therapeutics, Inc.
- Ticker
- CTNM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 3565 General Atomics Court, Suite 200, San Diego, CA 92121
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001855175
Recent SEC filings
- Sep 14, 2026
- Jul 30, 2026
- Jul 30, 2026
- Jul 13, 2026
- Jun 26, 2026
- May 5, 2026
- May 5, 2026
- Apr 30, 2026
Frequently asked questions
What is Contineum Therapeutics's stock price?
Contineum Therapeutics (CTNM) closed at $455.61 on Oct 9, 2026, up 0.19% from the previous close of $454.75.
What is Contineum Therapeutics's market cap?
Contineum Therapeutics's market cap is $10.52B, based on a share price of $455.61 and 23.1M shares outstanding as of Oct 27, 2025.
How much revenue does Contineum Therapeutics make?
Contineum Therapeutics reported revenue of $0.00 for fiscal 2024, down 100.00% from fiscal 2023.
Does Contineum Therapeutics pay a dividend?
Contineum Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Contineum Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures